Chad Thomas Campbell's most recent trade in Angiodynamic Inc was a trade of 395 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on July 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 395 | 63,587 (0%) | 0% | 7.1 | 2,816 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 359 | 63,982 (0%) | 0% | 7.1 | 2,560 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 19 Jul 2024 | 1,025 | 64,341 (0%) | 0% | 7.2 | 7,360 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 24,699 | 24,699 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 24,240 | 24,240 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 12,350 | 65,366 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 8,777 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 6,600 | 70,187 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 2,379 | 67,808 (0%) | 0% | 7.4 | 17,605 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.65 per share. | 20 Jul 2023 | 395 | 47,509 (0%) | 0% | 8.7 | 3,417 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.74 per share. | 20 Jul 2023 | 359 | 47,904 (0%) | 0% | 8.7 | 3,138 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 13,453 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 3,900 | 51,409 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.92 per share. | 19 Jul 2023 | 1,404 | 50,005 (0%) | 0% | 8.9 | 12,524 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.63 per share. | 14 Jul 2023 | 596 | 37,158 (0%) | 0% | 9.6 | 5,739 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 14 Jul 2023 | 279 | 36,879 (0%) | 0% | 9.6 | 2,667 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 9,341 | 9,341 | - | - | Non- Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,974 | 7,974 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 3,987 | 37,754 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 6,195 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 3,104 | 34,845 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.54 per share. | 07 Jul 2022 | 1,078 | 33,767 (0%) | 0% | 20.5 | 22,142 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.59 per share. | 05 Oct 2021 | 10,748 | 42,489 (0%) | 0% | 16.6 | 178,309 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 10,748 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Sale of securities on an exchange or to another person at price $ 27.15 per share. | 05 Oct 2021 | 10,748 | 31,741 (0%) | 0% | 27.1 | 291,808 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 8,210 | 34,871 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 7,079 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.29 per share. | 12 Aug 2021 | 3,130 | 31,741 (0%) | 0% | 27.3 | 85,418 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 26 Jul 2021 | 318 | 26,661 (0%) | 0% | 26.1 | 8,300 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 11,923 | 11,923 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.80 per share. | 26 Jul 2020 | 283 | 23,983 (0%) | 0% | 8.8 | 2,490 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.80 per share. | 26 Jul 2020 | 259 | 23,724 (0%) | 0% | 8.8 | 2,279 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.46 per share. | 17 Jul 2020 | 262 | 24,566 (0%) | 0% | 9.5 | 2,479 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.21 per share. | 17 Jul 2020 | 224 | 24,342 (0%) | 0% | 9.2 | 2,063 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.21 per share. | 17 Jul 2020 | 76 | 24,266 (0%) | 0% | 9.2 | 700 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 19,800 | 19,800 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 13,453 | 13,453 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 6,726 | 24,828 (0%) | 0% | 0 | Common Stock |